centocor inc said entered into agreement with for exclusive distribution centocor panorex japan panorex monoclonal antibody made through recombinant gene technology for treatment pancreatic cancer has been tested humans europe and since 1982 centocor said intends clinical trials this year with modified form drug under agreement ajinomoto will conduct clinical tests drug japan and both companies will jointly file for marketing approval for product japan reuter 